Feagan, Brian G <br/><br/>
Efficacy of Vedolizumab Induction and Maintenance Therapy in Patients With Ulcerative Colitis, Regardless of Prior Exposure to Tumor Necrosis Factor Antagonists.  [electronic resource] 

 -  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association  02 2017 
 - 229-239.e5 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1542-7714 
<br/><br/><label>Standard No.: </label>10.1016/j.cgh.2016.08.044  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies, Monoclonal, Humanized--therapeutic use<br/>Clinical Trials, Phase III as Topic<br/>Colitis, Ulcerative--drug therapy<br/>Female<br/>Gastrointestinal Agents--therapeutic use<br/>Humans<br/>Induction Chemotherapy--methods<br/>Maintenance Chemotherapy--methods<br/>Male<br/>Middle Aged<br/>Placebos--administration & dosage<br/>Randomized Controlled Trials as Topic<br/>Treatment Outcome